HP
KALA icon

Harbourvest Partners’s KALA BIO KALA Stock Holding History

Harbourvest Partners’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40
Closed -$872K – 32
2020
Q1 		$872K Hold
40
– – 0.42% 19
2019
Q4 		$366K Hold
40
– – 0.15% 29
2019
Q3 		$377K Hold
40
– – 0.16% 26
2019
Q2 		$633K Hold
40
– – 0.23% 24
2019
Q1 		$820K Hold
40
– – 0.29% 22
2018
Q4 		$485K Hold
40
– – 0.23% 26
2018
Q3 		$955K Buy
+40
New +$1.22M 0.86% 15

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbourvest Partners's KALA Position: Q2 2020 in Review

Harbourvest Partners sold out of KALA BIO (KALA) in Q2 2020, closing a stake of 40 shares — an estimated $872K sold.

Harbourvest Partners first reported a position in KALA in Q3 2018 and held it in 7 quarters. The position peaked at $955K in Q3 2018. 113 funds tracked by Wall St. Rank hold KALA as of Q2 2020.

  • Harbourvest Partners reported no remaining KALA BIO position as of Q2 2020 after selling out during the quarter.
  • Harbourvest Partners sold 40 KALA BIO shares in Q2 2020, an estimated $872K.
  • Harbourvest Partners first reported a position in KALA BIO in Q3 2018 and held it in 7 quarters.
  • Harbourvest Partners's KALA BIO position peaked at $955K in Q3 2018.
  • 113 funds tracked by Wall St. Rank held KALA BIO as of Q2 2020.

Based on Harbourvest Partners's 13F filing for Q2 2020, filed 13 Aug 2020.